Crewe Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-242	Closed	-$9.26K	–	875
2023 Q1	$9.26K	Hold	242	–	–	﹤0.01%	565
2022 Q4	$13.3K	Hold	242	–	–	﹤0.01%	496
2022 Q3	$8K	Hold	242	–	–	﹤0.01%	709
2022 Q2	$2K	Buy	+242	New	+$2K	﹤0.01%	956